Potential of mesenchymal- and cardiac progenitor cells for therapeutic targeting of B-cells and antibody responses in end-stage heart failure.

by Patricia van den Hoogen, Saskia C A de Jager, Emma A Mol, Arjan S Schoneveld, Manon M H Huibers, Aryan Vink, Pieter A Doevendans, Jon D Laman, Joost P G Sluijter
Published 2019-01-01

Anti-fibrotic Effects of Cardiac Progenitor Cells in a 3D-Model of Human Cardiac Fibrosis

by Tom C. L. Bracco Gartner, Tom C. L. Bracco Gartner, Tom C. L. Bracco Gartner, Tom C. L. Bracco Gartner, Janine C. Deddens, Janine C. Deddens, Emma A. Mol, Emma A. Mol, Marina Magin Ferrer, Linda W. van Laake, Linda W. van Laake, Linda W. van Laake, Carlijn V. C. Bouten, Ali Khademhosseini, Pieter A. Doevendans, Pieter A. Doevendans, Pieter A. Doevendans, Pieter A. Doevendans, Pieter A. Doevendans, Pieter A. Doevendans, Willem J. L. Suyker, Willem J. L. Suyker, Willem J. L. Suyker, Joost P. G. Sluijter, Joost P. G. Sluijter, Joost P. G. Sluijter, Jesper Hjortnaes, Jesper Hjortnaes, Jesper Hjortnaes
Published 2019-04-01